FDA Investigator Tomika L Bivens
Tomika L Bivens has conducted inspections on 23 sites in 4 countries as of 05 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
05 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Brazil,
United States of America,
India,
Argentina
FDA Investigators that have inspected at least one site in common with Tomika L Bivens:
Abdollah Koolivand,
Adam R Cooke,
Alan P Kurtzberg,
Anastasia M Shields,
Ann L Demarco,
Barbara M Frazier,
Bonita S Chester,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Christina H Owens,
Christopher S Keating,
Daniel J Roberts,
Devaughn Edwards,
Dipesh K Shah,
Edward Deberry,
Eric M Mueller, PharmD,
Erika V Butler,
Felix Maldonado,
Freddy Ortiz Colon,
Gabriel R Mclemore,
Guo Q Shen,
Hai Lient Phung,
Ibad U Khan,
Isabel Y Espinosa,
Jared P Stevens,
Jason K Morgan,
Jawaid Hamid,
Jeffrey P Raimondi,
Jorge L Guadalupe,
Jose A Lopez,
José E Meléndez,
Joseph F Owens,
Kemejumaka N Opara,
Kham Phommachanh,
Lareese K Thomas,
Lauryl A Smith,
Leslie W Gilbert,
Leslie W Jones,
Lillie D Witcher,
Lisa L Flores,
LT Tamara J Henderson,
Luckner Jean Marie,
Luis Mburgos Medero,
Marcellinus D Dordunoo,
Marian E Ramirez,
Marie F Mathews,
Massoud Motamed,
Melba Trivera Clavell,
Michael A Charles,
Michael J Kuchta,
Muralidhara B Gavini, PhD,
Myoshi M Francis,
N'jere English,
Nadeem I Chaudhry,
Noreen Muñiz,
Pankaj H Amin,
Parul M Patel,
Patrick C Klotzbuecher,
Paul W Moy,
Penny H Mccarver,
Pratik S Upadhyay, DDC,
Rachael L Cook,
Rafeeq A Habeeb,
Reba A Gates,
Richard E Needham,
Robert Q Green,
Robin N Goins,
Ronsha Y Hill,
Saied A Asbagh,
Santos E Camara,
Satheesh Thomas,
Scott N Lim,
Seneca D Toms,
Sherry R Dunn,
Simone M Edmonson,
Sixto M Mercado Rios,
Sony Mathews,
Susan O Oladeji,
Tamara M Casselman,
Tamika D Cathey,
Tara G Bizjak,
Tonshina R Hall,
Trang N Cox,
Tyrico K English,
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Viviana Matta
Tomika L Bivens's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more